Pfizer R&D Emphasizes M&A; Deal Structure, Integration To Be More Flexible
Pfizer anticipates that one-third of the six new products the company expects to launch annually beginning in 2011 will derive from enhanced external sourcing efforts
Pfizer anticipates that one-third of the six new products the company expects to launch annually beginning in 2011 will derive from enhanced external sourcing efforts